BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29946997)

  • 1. Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis.
    Meijer LL; Alberga AJ; de Bakker JK; van der Vliet HJ; Le Large TYS; van Grieken NCT; de Vries R; Daams F; Zonderhuis BM; Kazemier G
    Ann Surg Oncol; 2018 Sep; 25(9):2681-2692. PubMed ID: 29946997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior prognostic importance of perineural invasion vs. lymph node involvement after curative resection of duodenal adenocarcinoma.
    Cecchini S; Correa-Gallego C; Desphande V; Ligorio M; Dursun A; Wargo J; Fernàndez-del Castillo C; Warshaw AL; Ferrone CR
    J Gastrointest Surg; 2012 Jan; 16(1):113-20; discussion 120. PubMed ID: 22005894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study.
    Ecker BL; McMillan MT; Datta J; Dempsey DT; Karakousis GC; Fraker DL; Drebin JA; Mamtani R; Giantonio BJ; Roses RE
    Eur J Cancer; 2016 Dec; 69():135-141. PubMed ID: 27821316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of surgical resection for primary duodenal adenocarcinoma: A systematic review.
    Li D; Si X; Wan T; Zhou Y
    Asian J Surg; 2019 Jan; 42(1):46-52. PubMed ID: 29802028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
    Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
    Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of adjuvant chemoradiotherapy for duodenal cancer: a single center experience.
    Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Am J Clin Oncol; 2012 Dec; 35(6):533-6. PubMed ID: 21659832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal Adenocarcinoma: Profile and Predictors of Survival Outcomes.
    Oyasiji T; Alosi J; Tan W; Wilfong C; Wilkinson N
    Am Surg; 2015 Nov; 81(11):1125-33. PubMed ID: 26672582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Lymphadenectomy for Duodenal Adenocarcinoma: Does the Number Alone Matter?
    Sakamoto T; Saiura A; Ono Y; Mise Y; Inoue Y; Ishizawa T; Takahashi Y; Ito H
    Ann Surg Oncol; 2017 Oct; 24(11):3368-3375. PubMed ID: 28799027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Neo-Adjuvant Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma: A PRISMA-Compliant Meta-Analysis and Systematic Review.
    Liu W; Fu XL; Yang JY; Liu DJ; Li J; Zhang JF; Huo YM; Yang MW; Hua R; Sun YW
    Medicine (Baltimore); 2016 Apr; 95(15):e3009. PubMed ID: 27082545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes in patients with duodenal adenocarcinoma.
    Lee SY; Lee JH; Hwang DW; Kim SC; Park KM; Lee YJ
    ANZ J Surg; 2014 Dec; 84(12):970-5. PubMed ID: 23656271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival--a ten-year experience.
    Carr JA; Ajlouni M; Wollner I; Wong D; Velanovich V
    Am Surg; 1999 Dec; 65(12):1143-9. PubMed ID: 10597062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Adjuvant Chemoradiotherapy for Duodenal Cancer: An Updated Analysis of Long-Term Follow-Up from Single Institution.
    Jang BS; Park HJ; Kim K; Jang JY; Kim SW; Oh DY; Chie EK
    World J Surg; 2018 Oct; 42(10):3294-3301. PubMed ID: 29869181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver perfusion chemotherapy for selected patients at a high-risk of liver metastasis after resection of duodenal and ampullary cancers.
    Noda T; Ohigashi H; Ishikawa O; Eguchi H; Yamada T; Sasaki Y; Yano M; Imaoka S
    Ann Surg; 2007 Nov; 246(5):799-805. PubMed ID: 17968172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Node negative duodenal adenocarcinoma is associated with long-term patient survival following pancreaticoduodenal resection.
    Patel PH; Likos-Corbett M; Doyle J; Kumar S; Bhogal RH
    ANZ J Surg; 2022 May; 92(5):1105-1109. PubMed ID: 35403794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
    Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status.
    Kulaylat AS; Hollenbeak CS; Stewart DB
    Ann Surg Oncol; 2017 May; 24(5):1281-1288. PubMed ID: 27864695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Factors and Clinical Characteristics of Patients with Primary Duodenal Adenocarcinoma: A Single-Center Experience from China.
    Jiang QL; Huang XH; Chen YT; Zhang JW; Wang CF
    Biomed Res Int; 2016; 2016():6491049. PubMed ID: 28116301
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer Without Metastasectomy is Associated With Improved Overall Survival Compared With Chemotherapy/Radiation Therapy Alone.
    Gulack BC; Nussbaum DP; Keenan JE; Ganapathi AM; Sun Z; Worni M; Migaly J; Mantyh CR
    Dis Colon Rectum; 2016 Apr; 59(4):299-305. PubMed ID: 26953988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What prognostic factors are important in duodenal adenocarcinoma?
    Bakaeen FG; Murr MM; Sarr MG; Thompson GB; Farnell MB; Nagorney DM; Farley DR; van Heerden JA; Wiersema LM; Schleck CD; Donohue JH
    Arch Surg; 2000 Jun; 135(6):635-41; discussion 641-2. PubMed ID: 10843358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.